Obesity Flashcards

1
Q

Obesity - E/E

A

One of the most common d/o in medicine
According to WHO 500 million adults worldwide, 42 million children
Increased healthcare costs
Can be one of the most frustrating d/o to manage
Advances have been made with time
Continues to increase nationwide
Obesity stigma
Women > Men
68% of Americans are overweight based on BMI
Socioeconomic factors play a significant role
Ethnicity can have a major influence
Gentic predisposition
Medical condition
MULTIFACTORIAL!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Genetics and obesity

A

Five gene identified
All affect control of appetite from a neuroendocrine standpoint
- Leptin
- Grehlin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Economical Impacts of Obesity - Personal Level

A
$1,000's
Additional medication cost
Out-of-pocket healthcare expenses
Costs related to inactivity
Commercial weight loss program fees
Additional food costs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Economical Impacts of Obesity - National level

A

Billions yearly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Economical Impacts of Obesity - Business level

A

More than $12 billion for employee care

5% of total healthcare expenditures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Assessing obesity

A

EVERYONE!!
Record and trend BMI
Assess for co-morbid dz in anyone with a BMI of 25 or greater

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Obesity related Co-morbidities

A
DM-2
HTN
OSA
Dyslipidemia
OA
GERD
Ca
Back/joint pain
Urinary stress incontinence
Asthma
OHS
CAD / CHD
NASH / NAFLD
Pseudotumor cerebri
Infertility - PCOS
Psychological - Depression / Anxiety
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

BMI of normal weight

A

18.5 - 24.9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

BMI of overweight

A

25 - 29.9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

BMI of Obese (Class I)

A

30 - 34.9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

BMI of Obese (Class II)

A

35-39.9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

BMI of extremely obese (Class III)

A

40+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

BMI

A

A measurement based on weight and height

Used to help determine the degree or severity of a person’s obesity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Medical evaluation

A
Age of onset
Weight changes
FHx
Social hx
Occupational hx
Eating habits
Exercise habits
Previous effeorts to address
Assess for eating d/o
- Laxative use
- Diuretic use
- Nutritional supplements
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Secondary Obesity

A
<1% have an attributable cause
Hypothyroidism
Cushing's dz or syndrome
Other genetic conditions
- Prader-Willi Syndrome
- Alstrom Syndrome
- Cohen Syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Weight loss strategies - in general

A
Dietary intervention
Physical activity
Behavior modification
Drug tx
Weight loss sx in the severely obese
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Weight loss strategies - Dietary intervention

A

About 10% of body weight and be healthfully lost in 6 months

Diets are prone to failure for many reasons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Weight loss strategies - Physical activity

A

Increased activity can improve general health, but may have little impact on total body weight in morbid obesity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Weight loss strategies - behavior modification

A

Can contribut to overall weight loss program
Requires ongoing professional contact
Failure rate can be high

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Weight loss strategies - Drug tx

A

Weight is typically regained when tx ends

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Weight loss strategies - sx

A

Weight loss sx in the severely obese

The most effective approach for long-term weight loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Dietary intervention - in general

A

Changing dietary habits
Daily Caloric intake
Long term success of dieting alone is poor
The higher the weight loss the harder it is to keep it off

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Dietary intervention - Changing Dietary Habits

A

Diets

Calorie counting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Dietary intervention - Daily caloric intake

A
Requirements depend on numerous factors
- Age
- Sex
- Physical activity
- Health conditions
Males: 2000-3000 /day
Females: 1600-2400/day
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Dietary intervention - Long term success

A

Only 20% will lose 20 lbs and keep it off for 2 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Physical Activity

A

Calorie expenditure > intake
Typically a combination is best
5-7 days/week
Moderate Activity (100-130HR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What is the best way to optimize fatty weight loss

A

A combination of diet and exercise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Behavior Modification

A

Esp. if weight gain is related to psychological eating d/o
Maintenance
Social support system!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Medications - in general

A

OTC & prescriptions
Routine f/u
Do they work?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Medications - NIH/FDA recommendations

A

Part of comprehensive program
BMI > 30
BMI > 27 if they have a medical co-morbidity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Medications - Examples

A
Xenical (Orlistat)
Belviq (Lorcaserin)
Phentermine
Topriamate
Saxenda (Liraglutide)
Qsymia
Contrave
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Xenical (Orlistat)

A
Long term tx
TID with meals
MOA - GI tract
SE - GI
Risks - Malabsorption
2-4 kg > placebo
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Belviq (Lorcaserin)

A
Shorter term tx
MOA - SSRA
Risks
- NMS
- Serotonin syndrome
- Breast tumors?
- Valvular HD?
3% > weight loss than placebo
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Phentermine

A
Short term
Strict f/u is required
Two doses
- 15 mg
-37.5 mg
- QD 1-2h after breakfast
SE/risk
- Insomnia
- Fatigue
- CV
Better results
-7.8% &amp; 9.8% > placebo
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Topiramate

A

Anticonvulsant
Off label use for weight loss
Typical dose - 25mg BID
Black box warning - birth defects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Saxenda (liraglutide)

A
Injectable
Incretin (GLP-1 agonist)
FDA approved for weight loss
Dosage - 3 mg
SE - GI; Pancreatitis
Black box warning - carcinogen?
3.7-4.5% > loss than placebo at 1 year
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Combination drugs

A

Qsymia

Contrave

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Qsymia

A
Phentermine / Topirmate
Dosage: 7.5/46mg; 15/92 mg
Contraindication: Hyperthyroidism; Glaucoma
SE
- Dizziness
- Paresthesias
- CV
- Psychologial
- GI
Black box warning - Birth defects
6.7% &amp; 8.9% weight loss at 1 year
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Contrave

A
Bupropion / Naltrexone
Dosage
- 8/90 mg
- Complicated dosing to start medication
- EDUCATE!
Risk / SE
- CV outcome in trial progress (HTN; tachycardia)
- GI
- Neuropsychiatric
2-4% > Placebo
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Expectations of weight loss tx

A
Placebo
- 4-6% weight loss
- 0% (5 years)
Diet/behavior modification
- 8-12% weight loss
- 1.6% (10 years)
Drug therapy
- <10% weight loss
- 10% (5 years)
Gastric bypass sx
- 65-85% weight loss
- Up to 100% (5 years)
Lap. vert. sleeve gastrectomy
- 59% weight loss
- Up to 100% (5 years)
41
Q

Bariatric surgery - in general

A

An option for individuals who have failed more conservative measures
The single most effective means of long terms weight loss
M/M risks in sx < non-sx obese pts with chronic dz
US and Canada > 100,000 / year

42
Q

Bariatric surgery - Criteria

A
BMI > 40 w/o co-morbidity
BMI > 35 with obesity related co-morbidities
Must not have contraindications to sx
BMI 30-34.9 - metabolic
- Uncontrollable DM-2
- Metabolic syndrome
43
Q

Bariatric surgery - Contraindications

A
No absolute contraindications
Anorexia nervosa or bulimia nervosa
Scleroderma (consider lap band)
Surgeon must exercise good judgment in selection
- Cirrhosis
- Previous sx
- Large ventral hernias
- large hiatal hernias
 - various medical conditions (cardiomyopathy, stroke, sever coagulopathy)
- psychiatric illness
- OBD
- Connective tissue d/o
- Noncompliance
44
Q

Bariatric surgery - Choosing a surgeon

A

Research
Resources
Organized program / multidisciplinary program - support groups
Center of Excellence (ASMBS)

45
Q

Center of excellence

A

Training requirements
Procedure requirements - surgeon and facility
Hospital requirements - infrastructure
Program requirements - multidisciplinary

46
Q

Bariatric surgery - Preparing the patient for surgical referal

A

Referral
Enroll in a multidisciplinary program
Pt seminar

47
Q

Bariatric surgery - Pre-op requirements

A
Documented medically supervised wt loss w/o sig. reduction
Optimized co-morbidities
Behavior medicine
Dietary and exercise physiology eval
Meet with surgeon a minimum of two times
Assure pt's understanding f o post-op expectations
Pre-op testing
Pre-op low calorie diet
48
Q

Bariatric surgery - Procedures in general

A

Restrictive

Combination

49
Q

Bariatric surgery - Restrictive procedures

A

Sleeve gastrectomy (LVSG)
Adjustable gastric banding (AGB
Vertical banded gastroplasty (VBG)

50
Q

Bariatric surgery - Combination procedures

A
Roux-en-Y gastric bypass
Biliopancratic diversion (BPD)
Duodenal switch (DS)
51
Q

Adjustable gastric banding - Advantages

A
AGB
Not permanent
Less short term complications
Quick recovery
Same anatomy
20-50% EBWL
Lowest mortality and complication rates
52
Q

Adjustable gastric banding - Disadvantages

A
Foreign body
Frequent f/u
60% re-operation rate
Long-term complications high
Many require removal
53
Q

Adjustable gastric banding - Complications

A
Dysphagia
N/V
Pain (epigastric &amp; port site)
GERD
Aspiration
Band leak
Band slippage
Band erosion
Port leak
Flipped port
Esophageal dilation
54
Q

Roux-en-Y Gastric Bypass - In General

A
RNYGB
Overall very good weight loss
Combo procedure - restrictive and malabsorptive
Higher risk but better return
Instant improvement in DM/hyperglycemia
Less frequent f/u than AGB
Must monitor long-term for deficiencies
- Risk for hypovitaminosis
- Dependent upon length of limbs
55
Q

Roux-en-Y Gastric Bypass - Advantages

A
Rapid initial weight loss
Less frequent f/u required
No implant
Laparoscopic approach
Longer track record in US
56
Q

Roux-en-Y Gastric Bypass - Disadvantages

A
Stomach cutting, stapling and intestinal rerouting requires
Risk for hypovitaminosis
Higher short term complications and mortality rates than LAP-BAND
Potential for nutritional deficiencies
"Dumping  syndrome" can occur
Not adjustable
Difficult to reverse
Longer hospital stay and recovery
57
Q

Dumping syndrome

A

Massive insulin release b/c of something the pt ate

58
Q

Roux-en-Y Gastric Bypass - Complications (early)

A
Pneumonia - 0.14%
Oxygen insufficiency - 0.48%
Leaks - 2.05%
Wound infection - 2.98%
GI Bleeding / hemorrhage - 1.93%
PE - 0.41%
Bowel obstruction - 1.73%
Death - 0.23%
N / V
59
Q

Roux-en-Y Gastric Bypass - Complications (late)

A
Strictures - 4.73%
Incisional hernia (laproscopic) - 0.47%
Incisional Hernia (Open sx) - 8.58%
SBO - 3.15%
Anemia &amp; B12 deficiency
Ulcers / gastritis
Cholelithiasis
Internal hernia  / intestinal ischemia
60
Q

Roux-en-Y Gastric Bypass - complications (leaks)

A

Rare, but can occur at any 5 internal staple line
pH of gastric content is very irritating to lining of abdomen and internal organs
Can quickly lead to sever infection, septic shock
Death may result
Re-operation required to find and repair the leak
Early detection and tx is key!!!

61
Q

Most common leak site of the Roux-en-Y Gastric Bypass

A

Pouch to intestine

62
Q

Roux-en-Y Gastric Bypass - Outcome

A
60-70% EBWL
>75% control of co-morbidities
- DM-2 83.8% resolution
- HTN 75.4% resolution
- OSA 86.6 resolution
63
Q

Roux-en-Y Gastric Bypass - Supplementation

A

Adult multivitamin
Vit. B12
Calcium (citrate) plus Vit, D
Iron on occasion

64
Q

Laproscopic Vertical Sleeve Gastrectomy - In general

A
LVSG
Descendant of the BPD and DS
Initially used as a staged procedure
Restrictive only - endocrine influence
Maintain continuity
Risk < RNYGB
Risk > AGB
Still recommend supplementation however for low risk for hypovitaminosis
65
Q

Laproscopic Vertical Sleeve Gastrectomy - Grehlin influence

A

Member of Motilin family of gut peptide hormones
Ligand for growth hormone secretigogue receptor
90% secreted in stomach and duodenum P/D1 cells

66
Q

Function of Grehlin

A

Increase GH secretion
Increase food intake
Weight gain

67
Q

Laproscopic Vertical Sleeve Gastrectomy - Advantages

A
Laparoscopic
May be an option for carefully selected pts, including high-risk or super-super-obese pts
Mean excess weight loss at 1yr of 59%
No implanted medical device
Less frequent f/u required
Maintain continuity
68
Q

Laproscopic Vertical Sleeve Gastrectomy - Disadvantages

A

Stomach cutting adn stapling required
Not reversible
Inpatient hospital stay and somewhat longer recovery than gastric band
Insurance

69
Q

Laproscopic Vertical Sleeve Gastrectomy - Complications (early)

A
Hemorrhage (0.7-1.8%)
Leaks (0.7-0.8%
Death (0.39%)
Wound infection
PE
Pneumonia
Oxygen insufficiency
Stenosis
70
Q

vLaproscopic Vertical Sleeve Gastrectomy - Complications (late)

A
Structure
Acid reflux
Incisional hernia
SBO
Ulcers / gastritis
Cholelithiasis
71
Q

Laproscopic Vertical Sleeve Gastrectomy - Outcomes

A

Good weight loss and long term results
55-65% EBWL
Resolution of co-morbidities come with weight changes
Slower results but still excellent resolution potential

72
Q

Biliopancreatic Diversion with Duodenal Switch - in general

A

BPD-DS
Initially started as BPD alone
Pt selection is key
Close f/u is a must

73
Q

Biliopancreatic Diversion with Duodenal Switch - modifications

A

DS
Sleeve
Laparoscopic approach

74
Q

Biliopancreatic Diversion with Duodenal Switch - Advantages

A

Very rapid inital weight loss
Weight loss continues beyond 12m at a slower rate
No foreign body
Very good resolution of co-morbidities
Best EBWL of any wt loss procedure
Now laparoscopic and robotic approaches available
Good option for wt loss in super morbidly obese (esp. BMI>60)

75
Q

Biliopancreatic Diversion with Duodenal Switch - Disadvantages

A
Non-reversible
Staling/cutting of viscera
Hypovitaminosis
Close f/u requires
Longer hospital stay
Long term nutritional monitoring a must
76
Q

Biliopancreatic Diversion with Duodenal Switch - Complications (early)

A
Higher mortality - 30d rate 2.6-7.6%
Anastomotic leak
Duodenal stump leak
Intra-abdominal abscess
Hemorrhage
VTE
Bowel obstruction
N/V
77
Q

Biliopancreatic Diversion with Duodenal Switch - Late

A
Bowel obstruction
Internal hernia
Structure (2 locations)
Nutritional deficiency
- Iron
- Calcium / Vit. D
- B12
- Folate
- Fat soluble vitamins in certain situations
Diarrhea
Cholelithiasis
78
Q

Biliopancreatic Diversion with Duodenal Switch - Outcomes

A
EBWL 70-80%
DM-2 - 90% resolution at 12-36m
HTN - 50-80% resolution
OSA - 98% resolution
Dyslipidemia improvment / resolution
Better outcomes than any other procedure
79
Q

Vertical Banded Gastroplasty - In General

A

VBG
Not routinely performed any longer
Still a sig. amount of pts around

80
Q

Vertical Banded Gastroplasty - common complications

A

Staple line breakdown (gastrogastric fistula)
Gastric outlet obstruction
Incisional hernia

81
Q

Other weight loss surgeries - Types

A

Vagal N. stimulators
Gastric plication
Band over
Endoscopic gastric balloon

82
Q

Complications - N/V

In general

A

Often the most common complaint after sx
Typically acute post-op but can become chronic
Places at risk for dehydration post-op

83
Q

Complications - N/V

Tx

A
First line
- Zofran
- Reglan
- Phenergan
- Compazine
Second line
- Decadron
- Levsin
- Marinol
84
Q

Complications - Reflux

In general

A

More common in LVSG

Signifies underlying pathology in RNY/BPD but can be a sign of pathology with LVSG

85
Q

Complications - Reflux Associated complications

A

Ulcer
Stricture
Gastrogastric fistula

86
Q

Complications - Reflux

Work-up

A

UGI
EGD
24h pH - in select cases

87
Q

Complications - Reflex

Tx

A

PPI +/- Carafate

Sx to correct complication or to alleviate

88
Q

Complications - Anastomotic ulcer

In General

A

Common late complication of RNYGB, BPD

Located at the gastrojejunostomy

89
Q

Complications - Anastomotic ulcer

Dx and Tx

A

DX - EGD

TX

  • Educate
  • Referral back to bariatric surgeon
  • PPI
  • Carafate
  • Sx
90
Q

Complications - Strictures

In General

A

Can be seen in RNYGB, LVSG, BPD-DS
Often associated with smoking
RNY - gastrojejunostomy, jejunojejunostomy
LVSG - Insisura, GE junction (Angle of His)
BPD/DS - Duodenojejunostomy

91
Q

Complications - Strictures

Tx

A

STOP SMOKING!!!
PPI
EGD with dilation
Sx

92
Q

Complications - internal hernia

A

Can arise at any of the multiple mesenteric defects associated with any malabsorptive procedure
Must be a consideration in these pt with chronic post-prandial abdominal pain
Place pt at risk for an acute ischemic event involving affect segments

93
Q

Complications - internal hernia

Work-up and Tx

A

Work-up

  • Work-up may be negative
  • UGI / Small Bowel series
  • EGD
  • CT abdomen and pelvis with contrast
  • Diagnostic laparoscopy

Tx - sx (open vs. laparoscopic)

94
Q

Complications - Post-op

In general

A

Long term success is dependent on f/u
Monitor for short and long term complications
Monitor dietary habits, exercise habits, aid in accountability
Should see surgeon frequently in 1st year

95
Q

How often should post-op f/u for bariatric sx occur?

A

1 week
1 month
Quarterly
F/u yearly thereafter

Routine dietary, exercise and psychology f/u is a must

96
Q

Complications - Hypovitaminosis

A

Can be due to procedure
Can have influence from complications post procedure
Long term actid suppression meds can influence
Key players - B12, Magnesium, Calcium

97
Q

Supplementation - ASMBS Guidlines

A
Lifelong supplementation for all bariatric sx pts
Adult multivitamin
- Vit B12
- Iron
- Vit A
- Vit D3
- Folic Acid
- Thiamine (B1)
- Zinc
- Copper
- Vit C
- Biotin (optional)
Calcium / Vit. D
Vit. B12 - RNYGB, BDP-DS, Sleeve?
98
Q

PCP role - Pre-op

A

Assess all individuals at risk
Optimize medical conditions related to obesity
Medially managed weight loss regimen
Referral for behavior modification
Medications
Initiate referral process for bariatric sx
DOCUMENT

99
Q

PCP role - Post-op

A

Good communication with specialists - labs
Early and frequent f/u initially
Routine f/u long term
Co-morbidities
Be able to identify early and lat complications
Long-term nutritional mainentance
Refer back to bariatric surgeon with complications
If symptoms arise think common things but never forget to assess their post sx anatomy